Q2
Copy the MAL entry into your own directory
cp $CLIBD/monomers/m/MALcif ./
Then correctt it in your directory
And assign LIBIN ./MAL.cif
The program will read your corrected version and ignore the distributed
one.
Q1
If you run REFMAC the GUI under review restraints, it will detect and
make a LINK entry for you
Then you will need to use the GUI task - merge monomer library to
combine your corrected MAL with the new LINK
Run refmac again with XYZIN the output from "review restraints " task (
that will include a LINK record)
and it should/might! work..
Eleanor
Pioszak, Augie wrote:
>
> Hello All,
>
> I have two questions about refinement with Refmac5.
>
> 1. I have a protein structure that is C-terminally amidated. What is
> the best way to handle this?
>
> I was trying to use the sketcher to create my own library definition
> for the modifed amino acid, but then I had issues with the modified
> amino acid not being covalently linked to the rest of the protein. I’m
> guessing there is a better way, such as creating a definition for just
> the additional NH2 group and telling refmac how to covalently link it
> to the last amino acid, but I’m not sure how to do this.
>
> 2. I have a structure with maltose in it. The refmac library
> definition for maltose has atoms “O1” and “O1,” mislabeled as Carbons.
> How can I correct this?
>
> I know I can change it with the sketcher, but then it tells me the
> name MAL is already taken and I have to use another. I’d prefer to
> leave it as the standard MAL name.
>
> Thanks for any help. I apologize if these issues have been covered before.
>
> Augie
>
> Augen Pioszak, Ph.D.
>
> Postdoctoral Fellow
>
> Laboratory of Structural Sciences
>
> Van Andel Research Institute
>
> 333 Bostwick Ave. N.E.
>
> Grand Rapids, MI 49503
>
> phone: (616) 234-5399
>
> email: [log in to unmask] <mailto:[log in to unmask]>
>
> ------------------------------------------------------------------------
> **
> **This email message, including any attachments, is for the sole use
> of the intended recipient(s) and may contain confidential information.
> Any unauthorized review, use, disclosure or distribution is
> prohibited. If you are not the intended recipient(s) please contact
> the sender by reply email and destroy all copies of the original
> message. Thank you.**
> ------------------------------------------------------------------------
|